BRD-6929, a Selective HDAC 1/2 Inhibitor, Potentiates the Efficacy of GM Against Latent HIV-1
Histone deacetylase (HDAC) enzymes, including subtypes comprising class I (HDAC1, HDAC2, HDAC3, and HDAC8) and class II (HDAC 4–7, HDAC9 and HDAC10), control the deacetylation of histone and non-histone proteins.…